The DOI matches its Crossref record; 196 of the 196 references it cites were found in a registry or an index.
Peroxisome Proliferator–Activated Receptors as Transcriptional Nodal Points and Therapeutic Targets
Abstract
Peroxisome proliferator–activated receptors (PPARs) are ligand-activated transcription factors involved in the transcriptional regulation of key metabolic pathways such as lipid metabolism, adipogenesis, and insulin sensitivity. More recent work implicates all 3 PPAR isotypes (α, γ, and δ, also known as β or β/δ) in inflammatory and atherosclerotic pathways. Because these nuclear receptors are activated by extracellular signals and control multiple gene targets, PPARs can be seen as nodes that control multiple inputs and outputs involved in energy balance, providing insight into how metabolism and the vasculature may be integrated. The ongoing clinical use of fibrates, which activate PPARα, and thiazolidinediones, which activate PPARγ, establishes these receptors as viable drug targets, whereas considerable in vitro animal model and human surrogate marker studies suggest that PPAR activation may limit inflammation and atherosclerosis. Together, these various observations have stimulated intense interest in PPARs as therapeutic targets and led to large-scale cardiovascular end-point trials with PPAR agonists. The first of these studies has generated mixed results that require careful review, especially in anticipation of additional clinical trial data and ongoing attempts to develop novel PPAR modulators. Such analysis of the existing PPAR data, the appropriate use of currently approved PPAR agonists, and continued progress in PPAR therapeutics will be predicated on a better understanding of PPAR biology.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Network biology: understanding the cell's functional organization
Barabási, A.-L., & Oltvai, Z. N. (2004) · Nature Reviews Genetics · doi:10.1038/nrg1272 · Cited by 7,903
Central nervous system control of food intake
Schwartz, M. W., Woods, S. C., Porte, D., Seeley, R. J., & Baskin, D. G. (2000) · Nature · doi:10.1038/35007534 · Cited by 6,451
Dormandy, J. A., Charbonnel, B., Eckland, D. J., Erdmann, E., Massi-Benedetti, M., Moules, I. K., Skene, A. M., Tan, M. H., Lefèbvre, P. J., Murray, G. D., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67528-9 · Cited by 4,129
Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with Dyslipidemia
Frick, M. H., Elo, O., Haapa, K., Heinonen, O. P., Heinsalmi, P., Helo, P., Huttunen, J. K., Kaitaniemi, P., Koskinen, P., Manninen, V., et al. (1987) · New England Journal of Medicine · doi:10.1056/nejm198711123172001 · Cited by 3,881
A Cold-Inducible Coactivator of Nuclear Receptors Linked to Adaptive Thermogenesis
Puigserver, P., Wu, Z., Park, C. W., Graves, R., Wright, M., & Spiegelman, B. M. (1998) · Cell · doi:10.1016/s0092-8674(00)81410-5 · Cited by 3,864
Colhoun, H. M., Betteridge, D. J., Durrington, P. N., Hitman, G. A., W Neil, H. A., Livingstone, S. J., Thomason, M. J., Mackness, M. I., Charlton-Menys, V., & Fuller, J. H. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16895-5 · Cited by 3,755
Lehmann, J. M., Moore, L. B., Smith-Oliver, T. A., Wilkison, W. O., Willson, T. M., & Kliewer, S. A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.22.12953 · Cited by 3,625
The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation
Ricote, M., Li, A. C., Willson, T. M., Kelly, C. J., & Glass, C. K. (1998) · Nature · doi:10.1038/34178 · Cited by 3,525
Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators
Issemann, I., & Green, S. (1990) · Nature · doi:10.1038/347645a0 · Cited by 3,519
Rubins, H. B., Robins, S. J., Collins, D., Fye, C. L., Anderson, J. W., Elam, M. B., Faas, F. H., Linares, E., Schaefer, E. J., Schectman, G., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199908053410604 · Cited by 3,439
15-Deoxy-Δ12,14-Prostaglandin J2 is a ligand for the adipocyte determination factor PPARγ
Forman, B. M., Tontonoz, P., Chen, J., Brun, R. P., Spiegelman, B. M., & Evans, R. M. (1995) · Cell · doi:10.1016/0092-8674(95)90193-0 · Cited by 2,858
Kliewer, S. A., Sundseth, S. S., Jones, S. A., Brown, P. J., Wisely, G. B., Koble, C. S., Devchand, P., Wahli, W., Willson, T. M., Lenhard, J. M., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.9.4318 · Cited by 2,164
Forman, B. M., Chen, J., & Evans, R. M. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.9.4312 · Cited by 2,116
Adipose Tissue, Inflammation, and Cardiovascular Disease
Berg, A. H., & Scherer, P. E. (2005) · Circulation Research · doi:10.1161/01.res.0000163635.62927.34 · Cited by 2,113
The PPARs: From Orphan Receptors to Drug Discovery
Willson, T. M., Brown, P. J., Sternbach, D. D., & Henke, B. R. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm990554g · Cited by 1,816
Lee, S. S.-T., Pineau, T., Drago, J., Lee, E. J., Owens, J. W., Kroetz, D. L., Fernandez-Salguero, P. M., Westphal, H., & Gonzalez, F. J. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.6.3012 · Cited by 1,655
Peroxisome proliferator–activated receptor α mediates the adaptive response to fasting
Kersten, S., Seydoux, J., Peters, J. M., Gonzalez, F. J., Desvergne, B., & Wahli, W. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6223 · Cited by 1,649
PPARs and the complex journey to obesity
Evans, R. M., Barish, G. D., & Wang, Y.-X. (2004) · Nature Medicine · doi:10.1038/nm1025 · Cited by 1,602
Lehrke, M., & Lazar, M. A. (2005) · Cell · doi:10.1016/j.cell.2005.11.026 · Cited by 1,443
Barroso, I., Gurnell, M., Crowley, V. E. F., Agostini, M., Schwabe, J. W., Soos, M. A., Maslen, G. L., Williams, T. D. M., Lewis, H., Schafer, A. J., et al. (1999) · Nature · doi:10.1038/47254 · Cited by 1,368
A PPARγ-LXR-ABCA1 Pathway in Macrophages Is Involved in Cholesterol Efflux and Atherogenesis
Chawla, A., Boisvert, W. A., Lee, C.-H., Laffitte, B. A., Barak, Y., Joseph, S. B., Liao, D., Nagy, L., Edwards, P. A., Curtiss, L. K., et al. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00164-2 · Cited by 1,347
The PPARα–leukotriene B4 pathway to inflammation control
Devchand, P. R., Keller, H., Peters, J. M., Vazquez, M., Gonzalez, F. J., & Wahli, W. (1996) · Nature · doi:10.1038/384039a0 · Cited by 1,345
Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IκB kinase
Rossi, A., Kapahi, P., Natoli, G., Takahashi, T., Chen, Y., Karin, M., & Santoro, M. G. (2000) · Nature · doi:10.1038/47520 · Cited by 1,310
Peroxisome-Proliferator-Activated Receptor δ Activates Fat Metabolism to Prevent Obesity
Wang, Y.-X., Lee, C.-H., Tiep, S., Yu, R. T., Ham, J., Kang, H., & Evans, R. M. (2003) · Cell · doi:10.1016/s0092-8674(03)00269-1 · Cited by 1,296
A SUMOylation-dependent pathway mediates transrepression of inflammatory response genes by PPAR-γ
Pascual, G., Fong, A. L., Ogawa, S., Gamliel, A., Li, A. C., Perissi, V., Rose, D. W., Willson, T. M., Rosenfeld, M. G., & Glass, C. K. (2005) · Nature · doi:10.1038/nature03988 · Cited by 1,254
Chinetti, G., Lestavel, S., Bocher, V., Remaley, A. T., Neve, B., Torra, I. P., Teissier, E., Minnich, A., Jaye, M., Duverger, N., et al. (2001) · Nature Medicine · doi:10.1038/83348 · Cited by 1,170
Activation of human aortic smooth-muscle cells is inhibited by PPARα but not by PPARγ activators
Staels, B., Koenig, W., Habib, A., Merval, R., Lebret, M., Torra, I. P., Delerive, P., Fadel, A., Chinetti, G., Fruchart, J.-C., et al. (1998) · Nature · doi:10.1038/31701 · Cited by 1,134
Delerive, P., De Bosscher, K., Besnard, S., Vanden Berghe, W., Peters, J. M., Gonzalez, F. J., Fruchart, J.-C., Tedgui, A., Haegeman, G., & Staels, B. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.45.32048 · Cited by 1,089
Regulation of Muscle Fiber Type and Running Endurance by PPARδ
Wang, Y.-X., Zhang, C.-L., Yu, R. T., Cho, H. K., Nelson, M. C., Bayuga-Ocampo, C. R., Ham, J., Kang, H., & Evans, R. M. (2004) · PLoS Biology · doi:10.1371/journal.pbio.0020294 · Cited by 1,089
Chawla, A., Barak, Y., Nagy, L., Liao, D., Tontonoz, P., & Evans, R. M. (2001) · Nature Medicine · doi:10.1038/83336 · Cited by 1,069
Oliver, W. R., Shenk, J. L., Snaith, M. R., Russell, C. S., Plunket, K. D., Bodkin, N. L., Lewis, M. C., Winegar, D. A., Sznaidman, M. L., Lambert, M. H., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.091021198 · Cited by 1,046
Sorting out the roles of PPAR in energy metabolism and vascular homeostasis
Lefebvre, P. (2006) · Journal of Clinical Investigation · doi:10.1172/jci27989 · Cited by 962
Rosenfeld, M. G., Lunyak, V. V., & Glass, C. K. (2006) · Genes & Development · doi:10.1101/gad.1424806 · Cited by 952
Keller, H., Dreyer, C., Medin, J., Mahfoudi, A., Ozato, K., & Wahli, W. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.6.2160 · Cited by 948
Acquired and Inherited Lipodystrophies
Garg, A. (2004) · New England Journal of Medicine · doi:10.1056/nejmra025261 · Cited by 941
Transcriptional Regulation of Metabolism
Desvergne, B., Michalik, L., & Wahli, W. (2006) · Physiological Reviews · doi:10.1152/physrev.00025.2005 · Cited by 892
Haffner, S. M., Greenberg, A. S., Weston, W. M., Chen, H., Williams, K., & Freed, M. I. (2002) · Circulation · doi:10.1161/01.cir.0000025403.20953.23 · Cited by 884
The cardiac phenotype induced by PPARα overexpression mimics that caused by diabetes mellitus
Finck, B. N., Lehman, J. J., Leone, T. C., Welch, M. J., Bennett, M. J., Kovács, A. D., Han, X., Gross, R. W., Kozak, R., Lopaschuk, G. D., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci14080 · Cited by 879
Incidence of hospitalized rhabdomyolysis in patients treated with lipid-lowering drugs
Graham, D. J. (2004) · JAMA · doi:10.1001/jama.292.21.2585 · Cited by 875
Chawla, A., Schwarz, E. J., Dimaculangan, D. D., & Lazar, M. A. (1994) · Endocrinology · doi:10.1210/en.135.2.798 · Cited by 873
Göttlicher, M., Widmark, E., Li, Q., & Gustafsson, J. A. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.10.4653 · Cited by 857
Endothelial Dysfunction, Hemodynamic Forces, and Atherogenesisa
GIMBRONE, M. A., TOPPER, J. N., NAGEL, T., ANDERSON, K. R., & GARCIA‐CARDEÑA, G. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06318.x · Cited by 836
Li, A. C., Brown, K. K., Silvestre, M. J., Willson, T. M., Palinski, W., & Glass, C. K. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10370 · Cited by 833
Nesto, R. W., Bell, D., Bonow, R. O., Fonseca, V., Grundy, S. M., Horton, E. S., Le Winter, M., Porte, D., Semenkovich, C. F., Smith, S., et al. (2003) · Circulation · doi:10.1161/01.cir.0000103683.99399.7e · Cited by 829
PPAR and human metabolic disease
Semple, R. K. (2006) · Journal of Clinical Investigation · doi:10.1172/jci28003 · Cited by 827
Goldberg, R. B., Kendall, D. M., Deeg, M. A., Buse, J. B., Zagar, A. J., Pinaire, J. A., Tan, M. H., Khan, M. A., Perez, A. T., Jacober, S. J., et al. (2005) · Diabetes Care · doi:10.2337/diacare.28.7.1547 · Cited by 795
A novel therapy for colitis utilizing PPAR-γ ligands to inhibit the epithelial inflammatory response
Su, C. G., Wen, X., Bailey, S. T., Jiang, W., Rangwala, S. M., Keilbaugh, S. A., Flanigan, A., Murthy, S., Lazar, M. A., & Wu, G. D. (1999) · Journal of Clinical Investigation · doi:10.1172/jci7145 · Cited by 767
The cardiac phenotype induced by PPARα overexpression mimics that caused by diabetes mellitus
Finck, B. N., Lehman, J. J., Leone, T. C., Welch, M. J., Bennett, M. J., Kovacs, A., Han, X., Gross, R. W., Kozak, R., Lopaschuk, G. D., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0214080 · Cited by 763
Neuschwander-Tetri, B. A., Brunt, E. M., Wehmeier, K. R., Oliver, D., & Bacon, B. R. (2003) · Hepatology · doi:10.1002/hep.1840380427 · Cited by 751
Effect of ramipril on the incidence of diabetes
(2006) · New England Journal of Medicine · doi:10.1056/nejmoa065061 · Cited by 737
A pilot study of pioglitazone treatment for nonalcoholic steatohepatitis
Promrat, K., Lutchman, G., Uwaifo, G. I., Freedman, R. J., Soza, A., Heller, T., Doo, E., Ghany, M., Premkumar, A., Park, Y., et al. (2004) · Hepatology · doi:10.1002/hep.20012 · Cited by 726
Miyazaki, Y., Mahankali, A., Matsuda, M., Mahankali, S., Hardies, J., Cusi, K., Mandarino, L. J., & DeFronzo, R. A. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.6.8567 · Cited by 726
PPARs: therapeutic targets for metabolic disease
Berger, J. P., Akiyama, T. E., & Meinke, P. T. (2005) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2005.03.003 · Cited by 713
Mazzone, T., Meyer, P. M., Feinstein, S. B., Davidson, M. H., Kondos, G. T., D’Agostino, R. B., Perez, A., Provost, J.-C., & Haffner, S. M. (2006) · JAMA · doi:10.1001/jama.296.21.joc60158 · Cited by 674
Molecular determinants of crosstalk between nuclear receptors and toll-like receptors
Ogawa, S., Lozach, J., Benner, C., Pascual, G., Tangirala, R. K., Westin, S., Hoffmann, A., Subramaniam, S., David, M., Rosenfeld, M. G., et al. (2005) · Cell · doi:10.1016/j.cell.2005.06.029 · Cited by 647
Therapeutic roles of peroxisome proliferator-activated receptor agonists
Staels, B., & Fruchart, J.-C. (2005) · Diabetes · doi:10.2337/diabetes.54.8.2460 · Cited by 646
Peters, J. M., Lee, S. S. T., Li, W., Ward, J. M., Gavrilova, O., Everett, C., Reitman, M. L., Hudson, L. D., & Gonzalez, F. J. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.14.5119-5128.2000 · Cited by 633
Guan, Y., Hao, C., Cha, D. R., Rao, R., Lu, W., Kohan, D. E., Magnuson, M. A., Redha, R., Zhang, Y., & Breyer, M. D. (2005) · Nature Medicine · doi:10.1038/nm1278 · Cited by 608
Marx, N., Sukhova, G. K., Collins, T., Libby, P., & Plutzky, J. (1999) · Circulation · doi:10.1161/01.cir.99.24.3125 · Cited by 599
Self-citationNATURE OF THE HEPATOMEGALIC EFFECT PRODUCED BY ETHYL-CHLOROPHENOXY-ISOBUTYRATE IN THE RAT
HESS, R., STÄUBLI, W., & RIESS, W. (1965) · Nature · doi:10.1038/208856a0 · Cited by 594
Marx, N., Schönbeck, U., Lazar, M. A., Libby, P., & Plutzky, J. (1998) · Circulation Research · doi:10.1161/01.res.83.11.1097 · Cited by 587
Self-citationBarak, Y., Liao, D., He, W., Ong, E. S., Nelson, M. C., Olefsky, J. M., Boland, R., & Evans, R. M. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.012610299 · Cited by 586
Rubins, H. B. (2002) · Archives of Internal Medicine · doi:10.1001/archinte.162.22.2597 · Cited by 586
Thiazolidinedione Use, Fluid Retention, and Congestive Heart Failure
Nesto, R. W., Bell, D., Bonow, R. O., Fonseca, V., Grundy, S. M., Horton, E. S., Le Winter, M., Porte, D., Semenkovich, C. F., Smith, S., et al. (2004) · Diabetes Care · doi:10.2337/diacare.27.1.256 · Cited by 585
Transcriptional Repression of Atherogenic Inflammation: Modulation by PPARδ
Lee, C.-H., Chawla, A., Urbiztondo, N., Liao, D., Boisvert, W. A., & Evans, R. M. (2003) · Science · doi:10.1126/science.1087344 · Cited by 580
Li, A. C., Binder, C. J., Gutierrez, A., Brown, K. K., Plotkin, C. R., Pattison, J. W., Valledor, A. F., Davis, R. A., Willson, T. M., Witztum, J. L., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci18730 · Cited by 573
Nissen, S. E. (2005) · JAMA · doi:10.1001/jama.294.20.joc50147 · Cited by 556
McIntyre, T. M., Pontsler, A. V., Silva, A. R., St. Hilaire, A., Xu, Y., Hinshaw, J. C., Zimmerman, G. A., Hama, K., Aoki, J., Arai, H., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0135855100 · Cited by 550
Macrophages in Human Atheroma Contain PPARγ
Marx, N., Sukhova, G., Murphy, C., Libby, P., & Plutzky, J. (1998) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65540-x · Cited by 529
Self-citationThe role of PPAR-γ in macrophage differentiation and cholesterol uptake
Moore, K. J., Rosen, E. D., Fitzgerald, M. L., Randow, F., Andersson, L. P., Altshuler, D., Milstone, D. S., Mortensen, R. M., Spiegelman, B. M., & Freeman, M. W. (2001) · Nature Medicine · doi:10.1038/83328 · Cited by 513
Xin, X., Yang, S., Kowalski, J., & Gerritsen, M. E. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.13.9116 · Cited by 513
Pasceri, V., Wu, H. D., Willerson, J. T., & Yeh, E. T. H. (2000) · Circulation · doi:10.1161/01.cir.101.3.235 · Cited by 504
Delerive, P., Martin-Nizard, F., Chinetti, G., Trottein, F., Fruchart, J.-C., Najib, J., Duriez, P., & Staels, B. (1999) · Circulation Research · doi:10.1161/01.res.85.5.394 · Cited by 502
Marx, N., Duez, H., Fruchart, J.-C., & Staels, B. (2004) · Circulation Research · doi:10.1161/01.res.0000127122.22685.0a · Cited by 501
Prevention of Type 2 Diabetes With Troglitazone in the Diabetes Prevention Program
The Diabetes Prevention Program Research Group* (2005) · Diabetes · doi:10.2337/diabetes.54.4.1150 · Cited by 474
Pioglitazone Induces Mitochondrial Biogenesis in Human Subcutaneous Adipose Tissue In Vivo
Bogacka, I., Xie, H., Bray, G. A., & Smith, S. R. (2005) · Diabetes · doi:10.2337/diabetes.54.5.1392 · Cited by 467
Combinatorial roles of nuclear receptors in inflammation and immunity
Glass, C. K., & Ogawa, S. (2006) · Nature Reviews Immunology · doi:10.1038/nri1748 · Cited by 464
Gervois, P., Fruchart, J.-C., Delerive, P., & Staels, B. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m004045200 · Cited by 456
Ericsson, C.-G., de Faire, U., Grip, L., Svane, B., Hamsten, A., & Nilsson, J. (1996) · The Lancet · doi:10.1016/s0140-6736(96)91343-4 · Cited by 426
Bishop-Bailey, D., & Hla, T. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.24.17042 · Cited by 424
Liver Markers and Development of the Metabolic Syndrome
Hanley, A. J. G., Williams, K., Festa, A., Wagenknecht, L. E., D’Agostino, R. B., & Haffner, S. M. (2005) · Diabetes · doi:10.2337/diabetes.54.11.3140 · Cited by 419
&NA; (1996) · The Endocrinologist · doi:10.1097/00019616-199609000-00019 · Cited by 417
Tontonoz, P., Graves, R. A., Budavari, A. I., Erdjument-Bromage, H., Lui, M., Hu, E., Tempst, P., & Spiegelman, B. M. (1994) · Nucleic Acids Research · doi:10.1093/nar/22.25.5628 · Cited by 383
Retinoid X Receptor Heterodimers in the Metabolic Syndrome
Shulman, A. I., & Mangelsdorf, D. J. (2005) · New England Journal of Medicine · doi:10.1056/nejmra043590 · Cited by 380
Jackson, S. M., Parhami, F., Xi, X.-P., Berliner, J. A., Hsueh, W. A., Law, R. E., & Demer, L. L. (1999) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.19.9.2094 · Cited by 373
Dressel, U., Allen, T. L., Pippal, J. B., Rohde, P. R., Lau, P., & Muscat, G. E. O. (2003) · Molecular Endocrinology · doi:10.1210/me.2003-0151 · Cited by 372
Peroxisome Proliferator-Activated Receptors: Vascular and Cardiac Effects in Hypertension
Schiffrin, E. L., Amiri, F., Benkirane, K., Iglarz, M., & Diep, Q. N. (2003) · Hypertension · doi:10.1161/01.hyp.0000084370.74777.b6 · Cited by 369
Marx, N., Bourcier, T., Sukhova, G. K., Libby, P., & Plutzky, J. (1999) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.19.3.546 · Cited by 362
Self-citationMarx, N., Kehrle, B., Kohlhammer, K., Grüb, M., Koenig, W., Hombach, V., Libby, P., & Plutzky, J. (2002) · Circulation Research · doi:10.1161/01.res.0000014225.20727.8f · Cited by 331
Self-citationZhang, H., Zhang, A., Kohan, D. E., Nelson, R. D., Gonzalez, F. J., & Yang, T. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0501744102 · Cited by 317
Insulin Resistance and Cardiovascular Events With Low HDL Cholesterol
Robins, S. J., Rubins, H. B., Faas, F. H., Schaefer, E. J., Elam, M. B., Anderson, J. W., Collins, D., & on behalf of the VA-HIT Study Group (2003) · Diabetes Care · doi:10.2337/diacare.26.5.1513 · Cited by 308
PPARδ is a very low-density lipoprotein sensor in macrophages
Chawla, A., Lee, C.-H., Barak, Y., He, W., Rosenfeld, J., Liao, D., Han, J., Kang, H., & Evans, R. M. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0337331100 · Cited by 305
Marx, N., Mach, F., Sauty, A., Leung, J. H., Sarafi, M. N., Ransohoff, R. M., Libby, P., Plutzky, J., & Luster, A. D. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.12.6503 · Cited by 296
Self-citationCalnek, D. S., Mazzella, L., Roser, S., Roman, J., & Hart, C. M. (2003) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000044461.01844.c9 · Cited by 286
Inoue, I., Goto, S.-I., Matsunaga, T., Nakajima, T., Awata, T., Hokari, S., Komoda, T., & Katayama, S. (2001) · Metabolism · doi:10.1053/meta.2001.19415 · Cited by 283
Reginato, M. J., Krakow, S. L., Bailey, S. T., & Lazar, M. A. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.4.1855 · Cited by 277
Schupp, M., Clemenz, M., Gineste, R., Witt, H., Janke, J., Helleboid, S., Hennuyer, N., Ruiz, P., Unger, T., Staels, B., et al. (2005) · Diabetes · doi:10.2337/diabetes.54.12.3442 · Cited by 274
Finck, B. N., Bernal-Mizrachi, C., Han, D. H., Coleman, T., Sambandam, N., LaRiviere, L. L., Holloszy, J. O., Semenkovich, C. F., & Kelly, D. P. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.01.006 · Cited by 270
The Peroxisome Proliferator-activated Receptor δ Promotes Lipid Accumulation in Human Macrophages
Vosper, H., Patel, L., Graham, T. L., Khoudoli, G. A., Hill, A., Macphee, C. H., Pinto, I., Smith, S. A., Suckling, K. E., Wolf, C. R., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m108482200 · Cited by 268
Improvement of Cardiovascular Risk Markers by Pioglitazone Is Independent From Glycemic Control
Pfützner, A., Marx, N., Lübben, G., Langenfeld, M., Walcher, D., Konrad, T., & Forst, T. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.03.041 · Cited by 268
Hwang, J., Kleinhenz, D. J., Lassègue, B., Griendling, K. K., Dikalov, S., & Hart, C. M. (2005) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00474.2004 · Cited by 268
Ziouzenkova, O., Perrey, S., Asatryan, L., Hwang, J., MacNaul, K. L., Moller, D. E., Rader, D. J., Sevanian, A., Zechner, R., Hoefler, G., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0538015100 · Cited by 254
Self-citationSidhu, J. S., Kaposzta, Z., Markus, H. S., & Kaski, J. C. (2004) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000124890.40436.77 · Cited by 248
Activation of PPARβ/δ Induces Endothelial Cell Proliferation and Angiogenesis
Piqueras, L., Reynolds, A. R., Hodivala-Dilke, K. M., Alfranca, A., Redondo, J. M., Hatae, T., Tanabe, T., Warner, T. D., & Bishop-Bailey, D. (2007) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000250972.83623.61 · Cited by 246
Do Peroxisome Proliferating Compounds Pose a Hepatocarcinogenic Hazard to Humans?
Cattley, R. C., DeLuca, J., Elcombe, C., Fenner-Crisp, P., Lake, B. G., Marsman, D. S., Pastoor, T. A., Popp, J. A., Robinson, D. E., Schwetz, B., et al. (1998) · Regulatory Toxicology and Pharmacology · doi:10.1006/rtph.1997.1163 · Cited by 244
Choi, D., Kim, S.-K., Choi, S.-H., Ko, Y.-G., Ahn, C.-W., Jang, Y., Lim, S.-K., Lee, H.-C., & Cha, B.-S. (2004) · Diabetes Care · doi:10.2337/diacare.27.11.2654 · Cited by 243
Involvement of PPAR nuclear receptors in tissue injury and wound repair
Michalik, L. (2006) · Journal of Clinical Investigation · doi:10.1172/jci27958 · Cited by 239
The Prospective Pioglitazone Clinical Trial in Macrovascular Events (PROactive)
Charbonnel, B., Dormandy, J., Erdmann, E., Massi-Benedetti, M., Skene, A., & PROactive Study Group (2004) · Diabetes Care · doi:10.2337/diacare.27.7.1647 · Cited by 231
PPARα deficiency reduces insulin resistance and atherosclerosis in apoE-null mice
Tordjman, K., Bernal-Mizrachi, C., Zemany, L., Weng, S., Feng, C., Zhang, F., Leone, T. C., Coleman, T., Kelly, D. P., & Semenkovich, C. F. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11497 · Cited by 229
Increased CD36 protein as a response to defective insulin signaling in macrophages
Liang, C.-P., Han, S., Okamoto, H., Carnemolla, R., Tabas, I., Accili, D., & Tall, A. R. (2004) · Journal of Clinical Investigation · doi:10.1172/jci19528 · Cited by 225
The PPAR regulatory system in cardiac physiology and disease
FINCK, B. (2007) · Cardiovascular Research · doi:10.1016/j.cardiores.2006.08.023 · Cited by 223
Chitturi, S., & George, J. (2002) · Seminars in Liver Disease · doi:10.1055/s-2002-30102 · Cited by 216
Dexamethasone induction of hypertension and diabetes is PPAR-α dependent in LDL receptor–null mice
Bernal-Mizrachi, C., Weng, S., Feng, C., Finck, B. N., Knutsen, R. H., Leone, T. C., Coleman, T., Mecham, R. P., Kelly, D. P., & Semenkovich, C. F. (2003) · Nature Medicine · doi:10.1038/nm898 · Cited by 212
Neurobiological basis of depression: an update
Kalia, M. (2005) · Metabolism · doi:10.1016/j.metabol.2005.01.009 · Cited by 201
Oxidized phospholipids activate PPARα in a phospholipase A2‐dependent manner
Delerive, P., Furman, C., Teissier, E., Fruchart, J.-C., Duriez, P., & Staels, B. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)01364-8 · Cited by 199
Inoue, I., Shino, K., Noji, S., Awata, T., & Katayama, S. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.8622 · Cited by 199
Fenofibrate and Rosiglitazone Lower Serum Triglycerides with Opposing Effects on Body Weight
Chaput, E., Saladin, R., Silvestre, M., & Edgar, A. D. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.2647 · Cited by 199
Sidhu, J. S., Cowan, D., & Kaski, J.-C. (2003) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2003.04.001 · Cited by 197
PPARα Agonists Inhibit Tissue Factor Expression in Human Monocytes and Macrophages
Neve, B. P., Corseaux, D., Chinetti, G., Zawadzki, C., Fruchart, J.-C., Duriez, P., Staels, B., & Jude, B. (2001) · Circulation · doi:10.1161/01.cir.103.2.207 · Cited by 191
Zhu, Y., Kan, L., Qi, C., Kanwar, Y. S., Yeldandi, A. V., Rao, M. S., & Reddy, J. K. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.18.13510 · Cited by 187
Troglitazone-induced liver failure: a case study
Graham, D. J., Green, L., Senior, J. R., & Nourjah, P. (2003) · The American Journal of Medicine · doi:10.1016/s0002-9343(02)01529-2 · Cited by 186
Duez, H., Chao, Y.-S., Hernandez, M., Torpier, G., Poulain, P., Mundt, S., Mallat, Z., Teissier, E., Burton, C. A., Tedgui, A., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m206966200 · Cited by 186
Kurtz, T. W., & Pravenec, M. (2004) · Journal of Hypertension · doi:10.1097/00004872-200412000-00003 · Cited by 182
An open-label trial of the PPARgamma ligand rosiglitazone for active ulcerative colitis
Lewis, J. D., Lichtenstein, G. R., Stein, R. B., Deren, J. J., Judge, T. A., Fogt, F., Furth, E. E., Demissie, E. J., Hurd, L. B., Su, C. G., et al. (2001) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2001.05333.x · Cited by 181
Effect of pioglitazone on body composition and energy expenditure: a randomized controlled trial
Smith, S. R., de Jonge, L., Volaufova, J., Li, Y., Xie, H., & Bray, G. A. (2005) · Metabolism · doi:10.1016/j.metabol.2004.07.008 · Cited by 176
Obesity, Peroxisome Proliferator-Activated Receptor, and Atherosclerosis in Type 2 Diabetes
Blaschke, F., Takata, Y., Caglayan, E., Law, R. E., & Hsueh, W. A. (2006) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000191663.12164.77 · Cited by 176
PPARα Activators Inhibit Tissue Factor Expression and Activity in Human Monocytes
Marx, N., Mackman, N., Schönbeck, U., Yilmaz, N., Hombach, V., Libby, P., & Plutzky, J. (2001) · Circulation · doi:10.1161/01.cir.103.2.213 · Cited by 175
Self-citationTargher, G., Bertolini, L., Padovani, R., Poli, F., Scala, L., Tessari, R., Zenari, L., & Falezza, G. (2006) · Diabetic Medicine · doi:10.1111/j.1464-5491.2006.01817.x · Cited by 173
Yue, T.-L., Bao, W., Gu, J.-L., Cui, J., Tao, L., Ma, X.-L., Ohlstein, E. H., & Jucker, B. M. (2005) · Diabetes · doi:10.2337/diabetes.54.2.554 · Cited by 170
Polikandriotis, J. A., Mazzella, L. J., Rupnow, H. L., & Hart, C. M. (2005) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000177805.65864.d4 · Cited by 169
Sethi, S., Ziouzenkova, O., Ni, H., Wagner, D. D., Plutzky, J., & Mayadas, T. N. (2002) · Blood · doi:10.1182/blood-2002-01-0316 · Cited by 166
Self-citationMarx, N., Wöhrle, J., Nusser, T., Walcher, D., Rinker, A., Hombach, V., Koenig, W., & Höher, M. (2005) · Circulation · doi:10.1161/circulationaha.105.535484 · Cited by 165
Szapary, P. O., Bloedon, L. T., Samaha, F. F., Duffy, D., Wolfe, M. L., Soffer, D., Reilly, M. P., Chittams, J., & Rader, D. J. (2006) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000195790.24531.4f · Cited by 162
Gizard, F., Amant, C., Barbier, O., Bellosta, S., Robillard, R., Percevault, F., Sevestre, H., Krimpenfort, P., Corsini, A., Rochette, J., et al. (2005) · Journal of Clinical Investigation · doi:10.1172/jci22756 · Cited by 160
Lipoprotein Lipase S447X: A Naturally Occurring Gain-of-Function Mutation
Rip, J., Nierman, M. C., Ross, C. J., Jukema, J. W., Hayden, M. R., Kastelein, J. J. P., Stroes, E. S. G., & Kuivenhoven, J. A. (2006) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000219283.10832.43 · Cited by 157
The DREAM Trial Investigators (2004) · Diabetologia · doi:10.1007/s00125-004-1485-5 · Cited by 153
Muhlestein, J. B., May, H. T., Jensen, J. R., Horne, B. D., Lanman, R. B., Lavasani, F., Wolfert, R. L., Pearson, R. R., Yannicelli, H. D., & Anderson, J. L. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.05.009 · Cited by 141
Peroxisome Proliferator-Activated Receptor α/γ Dual Agonists for the Treatment of Type 2 Diabetes
Henke, B. R. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm030631e · Cited by 141
Han, C. Y., Chiba, T., Campbell, J. S., Fausto, N., Chaisson, M. L., Orasanu, G., Plutzky, J., & Chait, A. (2006) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000227472.70734.ad · Cited by 140
Self-citationPPARγ and the control of adipogenesis
Spiegelman, B. M., Hu, E., Kim, J. B., & Brun, R. P. (1997) · Biochimie · doi:10.1016/s0300-9084(97)81500-3 · Cited by 137
Liou, J., Lee, S., Ghelani, D., Matijevic‐Aleksic, N., & Wu, K. K. (2006) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000223875.14120.93 · Cited by 137
Characterization of renin activity in brown adipose tissue
Shenoy, U., & Cassis, L. A. (1997) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1997.272.3.c989 · Cited by 135
The retinoid X receptor enhances the function of the peroxisome proliferator activated receptor
Issemann, I., Prince, R. A., Tugwood, J. D., & Green, S. (1993) · Biochimie · doi:10.1016/0300-9084(93)90084-6 · Cited by 134
Samaha, F. F., Szapary, P. O., Iqbal, N., Williams, M. M., Bloedon, L. T., Kochar, A., Wolfe, M. L., & Rader, D. J. (2005) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000200136.56716.30 · Cited by 129
Duez, H., Lefebvre, B., Poulain, P., Pineda‐Torra, I., Percevault, F., Luc, G., Peters, J. M., Gonzalez, F. J., Gineste, R., Helleboid, S., et al. (2004) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000154140.73570.00 · Cited by 121
Haubenwallner, S., Essenburg, A. D., Barnett, B. C., Pape, M. E., Demattos, R. B., Krause, B. R., Minton, L. L., Auerbach, B. J., Newton, R. S., & Leff, T. (1995) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)41090-9 · Cited by 118
Yoshimoto, T., Naruse, M., Nishikawa, M., Naruse, K., Tanabe, A., Seki, T., Imaki, T., Demura, R., Aikawa, E., & Demura, H. (1997) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1997.272.6.e989 · Cited by 117
DNA Binding-Independent Induction of I B Gene Transcription by PPAR
Delerive, P., Bosscher, K. D., Berghe, W. V., Fruchart, J., Haegeman, G., & Staels, B. (2002) · Molecular Endocrinology · doi:10.1210/mend.16.5.0826 · Cited by 116
Campia, U., Matuskey, L. A., & Panza, J. A. (2006) · Circulation · doi:10.1161/circulationaha.105.549618 · Cited by 112
Buchanan, T. A., Xiang, A. H., Peters, R. K., Kjos, S. L., Berkowitz, K. M., Marroquin, A., Goico, J., Ochoa, C., & Azen, S. P. (2000) · Diabetes · doi:10.2337/diabetes.49.5.782 · Cited by 111
Teissier, E., Nohara, A., Chinetti, G., Paumelle, R., Cariou, B., Fruchart, J.-C., Brandes, R. P., Shah, A., & Staels, B. (2004) · Circulation Research · doi:10.1161/01.res.0000150594.95988.45 · Cited by 110
PPAR? in endothelial cells influences high fat diet-induced hypertension
Nicol, C. J. B., ADACHI, M., AKIYAMA, T., & Gonzalez, F. J. (2005) · American Journal of Hypertension · doi:10.1016/j.amjhyper.2004.10.032 · Cited by 105
Walker, A. B., Naderali, E. K., Chattington, P., Buckingham, R. E., & Williams, G. (1998) · Diabetes · doi:10.2337/diabetes.47.5.810 · Cited by 100
Considerations for management of fluid dynamic issues associated with thiazolidinediones
Hollenberg, N. K. (2003) · The American Journal of Medicine · doi:10.1016/j.amjmed.2003.09.018 · Cited by 97
PPARs as Therapeutic Targets: Reverse Cardiology?
Plutzky, J. (2003) · Science · doi:10.1126/science.1091172 · Cited by 93
Self-citationThe Antidiabetic Agent Thiazolidinedione Stimulates the Interaction between PPARγ and CBP
Mizukami, J., & Taniguchi, T. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.7602 · Cited by 90
Lutchman, G. A., Promrat, K., Kleiner, D. E., Heller, T., Ghany, M. G., Yanovski, J. A., Liang, T. J., & Hoofnagle, J. H. (2006) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2006.05.005 · Cited by 90
Matsuura, H., Adachi, H., Smart, R. C., Xu, X., Arata, J., & Jetten, A. M. (1999) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(98)00214-7 · Cited by 89
Ahmed, W., Orasanu, G., Nehra, V., Asatryan, L., Rader, D. J., Ziouzenkova, O., & Plutzky, J. (2006) · Circulation Research · doi:10.1161/01.res.0000205846.46812.be · Cited by 84
Self-citationVaidya, S., Somers, E. P., Wright, S. D., Detmers, P. A., & Bansal, V. S. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.11.6187 · Cited by 83
Vaidya, S., Somers, E. P., Wright, S. D., Detmers, P. A., & Bansal, V. S. (1999) · PubMed · Cited by 81
Thiazolidinediones, peripheral oedema and congestive heart failure: what is the evidence?
Patel, C. B., Wyne, K. L., & McGuire, D. K. (2005) · Diabetes and Vascular Disease Research · doi:10.3132/dvdr.2005.010 · Cited by 80
Hennuyer, N., Tailleux, A., Torpier, G., Mezdour, H., Fruchart, J., Staels, B., & Fiévet, C. (2005) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000175756.56818.ee · Cited by 80
Ghanim, H., Dhindsa, S., Aljada, A., Chaudhuri, A., Viswanathan, P., & Dandona, P. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2609 · Cited by 76
Chen, J., Kinyamu, H. K., & Archer, T. (2005) · Molecular Endocrinology · doi:10.1210/me.2005-0192 · Cited by 76
Joner, M., Farb, A. A., Cheng, Q., Finn, A. V., Acampado, E., BURKE, A. P., Skorija, K., Creighton, W., Kolodgie, F. D., Gold, H. K., et al. (2006) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000251021.28725.e8 · Cited by 74
Molavi, B., Chen, J., & Mehta, J. L. (2006) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00926.2005 · Cited by 72
Laminar Flow Activates Peroxisome Proliferator-Activated Receptor-γ in Vascular Endothelial Cells
Liu, Y., Zhu, Y., Rannou, F., et al. (2004) · Circulation · doi:10.1161/01.cir.0000139850.08365.ec · Cited by 72
Rip, J., Nierman, M. C., Wareham, N. J., Luben, R., Bingham, S. A., Day, N., van Miert, J. N. I., Hutten, B. A., Kastelein, J. J. P., Kuivenhoven, J. A., et al. (2005) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000201038.47949.56 · Cited by 71
Jones, D. C., Ding, X., Zhang, T. Y., & Daynes, R. A. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.1.196 · Cited by 68
Meisner, F. G., Walcher, D., Gizard, F., Kapfer, X., Huber, R., Noak, A., Sunder-Plassmann, L., Bach, H., Haug, C., Bachem, M. G., et al. (2006) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000203511.66681.7f · Cited by 68
Jia, Y., Guo, G. L., Surapureddi, S., Sarkar, J., Qi, C., Guo, D., Xia, J., Kashireddy, P. V., Yu, S., Cho, Y., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506000102 · Cited by 65
Ziouzenkova, O., Asatryan, L., Sahady, D., Orasanu, G., Perrey, S., Cutak, B. J., Hassell, T., Akiyama, T. E., Berger, J. P., Sevanian, A., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m306786200 · Cited by 64
Self-citationPrediction of PPAR- ligand-mediated physiological changes using gene expression profiles
Frederiksen, K. S., Wulff, E. M., Sauerberg, P., Mogensen, J. P., Jeppesen, L., & Fleckner, J. (2003) · Journal of Lipid Research · doi:10.1194/jlr.m300239-jlr200 · Cited by 63
Nigro, J., Dilley, R. J., & Little, P. J. (2002) · Atherosclerosis · doi:10.1016/s0021-9150(01)00704-3 · Cited by 61
Peroxisome Proliferator-Activated Receptors and Liver X Receptors in Atherosclerosis and Immunity
Barish, G. D. (2006) · Journal of Nutrition · doi:10.1093/jn/136.3.690 · Cited by 57
Schaefer, K. L., Denevich, S., Ma, C., Cooley, S. R., Nakajima, A., Wada, K., Schlezinger, J. J., Sherr, D. H., & Saubermann, L. J. (2005) · Inflammatory Bowel Diseases · doi:10.1097/01.mib.0000160770.94199.9b · Cited by 56
Fenofibrate prevents obesity and hypertriglyceridemia in low-density lipoprotein receptor-null mice
Jeong, S., Kim, M. K., Han, M., Lee, H., Ahn, J., Kim, M., Song, Y., Shin, C.-O., Nam, K., Kim, T. W., et al. (2004) · Metabolism · doi:10.1016/j.metabol.2003.12.010 · Cited by 45
Schultze, A. E., Alborn, W. E., Newton, R. K., & Konrad, R. J. (2005) · Journal of Lipid Research · doi:10.1194/jlr.c500010-jlr200 · Cited by 43
After FIELD: should fibrates be used to prevent cardiovascular disease in diabetes?
Colhoun, H. M. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67668-4 · Cited by 41
Fine Tuning of PPAR Ligands for Type 2 Diabetes and Metabolic Syndrome
Ramachandran, U., Kumar, R., & Mittal, A. (2006) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/138955706776876140 · Cited by 40
Rennings, A. J. M., Smits, P., Stewart, M. W., & Tack, C. J. (2006) · Diabetes Care · doi:10.2337/diacare.29.03.06.dc05-01467 · Cited by 37
Troglitazone inhibits mitogenic signaling by insulin in vascular smooth muscle cells.
Goetze, S., Kim, S., Xi, X., Graf, K., Yang, D., Fleck, E., Meehan, W. P., Hsueh, W. A., & Law, R. (2000) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-200005000-00011 · Cited by 37
Subramanian, S., DeRosa, M. A., Bernal-Mizrachi, C., Laffely, N., Cade, W. T., Yarasheski, K. E., Cryer, P. E., & Semenkovich, C. F. (2006) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00230.2006 · Cited by 34
Oxidative Stress and Peroxisome Proliferator–Activated Receptors: Reversing the Curse?
Devchand, P. R., Ziouzenkova, O., & Plutzky, J. (2004) · Circulation Research · doi:10.1161/01.res.0000151331.69399.b2 · Cited by 29
Self-citationSingh, J. P., Kauffman, R. F., Bensch, W. R., Wang, G.-M., McClelland, P., Bean, J. S., Montrose, C., Mantlo, N. B., & Wagle, A. (2005) · Molecular Pharmacology · doi:10.1124/mol.105.010991 · Cited by 23
Zahradka, P. C., Yurkova, N., Litchie, B., Moon, M. C., Rizzo, D. F. D., & Taylor, C. G. (2003) · Springer eBooks · doi:10.1007/978-1-4615-0298-2_15 · Cited by 22
American Diabetes Association 60th Scientific Sessions,2000
Bloomgarden, Z. T. (2001) · Diabetes Care · doi:10.2337/diacare.24.1.162 · Cited by 21
Zahradka, P. C., Yurkova, N., Litchie, B., Moon, M. C., Rizzo, D. F. D., & Taylor, C. G. (2003) · Molecular and Cellular Biochemistry · doi:10.1023/a:1023424500160 · Cited by 19
Migita, H., & Morser, J. (2005) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000156482.76228.d1 · Cited by 16
American Diabetes Association - 60th scientific sessions.
Worker, C. (2000) · PubMed · Cited by 16
Ppar-Gamma Effects on the Vasculature
Hsueh, W. A. (2001) · Journal of Investigative Medicine · doi:10.2310/6650.2001.34109 · Cited by 11
Cited by
(1998) · PubMed · Cited by 2,737
Obesity, inflammation, and atherosclerosis
Rocha, V. Z., & Libby, P. (2009) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2009.55 · Cited by 994
Molecular Actions of PPARα in Lipid Metabolism and Inflammation
Bougarne, N., Weyers, B., Desmet, S. J., Deckers, J., Ray, D. W., Staels, B., & De Bosscher, K. (2018) · Endocrine Reviews · doi:10.1210/er.2018-00064 · Cited by 898
Cardiovascular disease risk in type 2 diabetes mellitus: insights from mechanistic studies
Mazzone, T., Chait, A., & Plutzky, J. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60768-0 · Cited by 545
Self-citationMirza, A. Z., Althagafi, I. I., & Shamshad, H. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2019.01.067 · Cited by 544
Metadata
- Authors
- Brown, J. D., & Plutzky, J.
- Venue
- Circulation
- Published
- 2007-01-30
- Volume
- 115
- Issue
- 4
- Pages
- 518-533
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2148521985
- Cited by
- 340
- References
- 196
- FWCI
- 13.05
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.